Insufficient scRNA-seq data for expression of NDST2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3558.96 | 578 / 578 | 1% | 0.01 | 9 / 1155 |
intestine | 100% | 2921.05 | 966 / 966 | 1% | 0.01 | 4 / 527 |
breast | 100% | 2968.99 | 459 / 459 | 1% | 0.01 | 6 / 1118 |
bladder | 100% | 3145.81 | 21 / 21 | 0% | 0.01 | 2 / 504 |
kidney | 100% | 2154.43 | 89 / 89 | 0% | 0.01 | 3 / 901 |
pancreas | 100% | 1579.28 | 327 / 328 | 1% | 0.01 | 1 / 178 |
prostate | 100% | 3299.98 | 245 / 245 | 0% | 0.00 | 1 / 502 |
adipose | 100% | 2962.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 100% | 3145.25 | 258 / 258 | 0% | 0 | 0 / 230 |
liver | 100% | 1152.97 | 226 / 226 | 0% | 0 | 0 / 406 |
ovary | 100% | 3082.98 | 180 / 180 | 0% | 0 | 0 / 430 |
skin | 100% | 3112.82 | 1809 / 1809 | 0% | 0 | 0 / 472 |
spleen | 100% | 6552.68 | 241 / 241 | 0% | 0 | 0 / 0 |
stomach | 100% | 2256.14 | 359 / 359 | 0% | 0 | 0 / 286 |
thymus | 100% | 2970.84 | 653 / 653 | 0% | 0 | 0 / 605 |
uterus | 100% | 3375.77 | 170 / 170 | 0% | 0 | 0 / 459 |
esophagus | 100% | 3099.65 | 1444 / 1445 | 0% | 0 | 0 / 183 |
blood vessel | 100% | 2391.18 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 4109.83 | 921 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 1331.13 | 848 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 1046.05 | 786 / 803 | 0% | 0 | 0 / 0 |
brain | 97% | 1821.24 | 2571 / 2642 | 0% | 0.00 | 1 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002002 | Biological process | regulation of angiotensin levels in blood |
GO_0002448 | Biological process | mast cell mediated immunity |
GO_0015014 | Biological process | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process |
GO_0015015 | Biological process | heparan sulfate proteoglycan biosynthetic process, enzymatic modification |
GO_0030210 | Biological process | heparin biosynthetic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0015016 | Molecular function | [heparan sulfate]-glucosamine N-sulfotransferase activity |
GO_0102140 | Molecular function | heparan sulfate N-deacetylase activity |
GO_0019213 | Molecular function | deacetylase activity |
GO_0050119 | Molecular function | N-acetylglucosamine deacetylase activity |
Gene name | NDST2 |
Protein name | Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 2) (NDST-2) (N-heparan sulfate sulfotransferase 2) (N-HSST 2) [Includes: Heparan sulfate N-deacetylase 2 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 2 (EC 2.8.2.-)] Sulfotransferase (EC 2.8.2.-) |
Synonyms | HSST2 |
Description | FUNCTION: Essential bifunctional enzyme that catalyzes both the N-deacetylation and the N-sulfation of glucosamine (GlcNAc) of the glycosaminoglycan in heparan sulfate. Modifies the GlcNAc-GlcA disaccharide repeating sugar backbone to make N-sulfated heparosan, a prerequisite substrate for later modifications in heparin biosynthesis. Plays a role in determining the extent and pattern of sulfation of heparan sulfate. Required for the exosomal release of SDCBP, CD63 and syndecan . . |
Accessions | ENST00000299641.8 [P52849-1] ENST00000429742.1 ENST00000309979.11 [P52849-1] H7C032 P52849 |